Companies: 10,795·Total market cap: $144.5T
Swedish Orphan Biovitrum AB (publ)

Swedish Orphan Biovitrum AB (publ)

BIOVFOTCHealthcare● Active
$47.35
$-0.13(-0.26%)
Market Cap$16.4B
P/E Ratio
52W High$48
52W Low$27.06
Overview

Swedish Orphan Biovitrum AB (publ) (BIOVF) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · BIOVF · as of Jun 9, 2026

Key Statistics

EPS (TTM)$2.70biovf eps ttm · biovf earnings per shareEarnings history
PE Ratio (TTM)17.5×biovf pe ratio ttm · biovf price to earningsPE Ratio deep dive
Revenue (TTM)$28.9Bbiovf revenue ttm · biovf annual revenueFull revenue history
Dividend YieldNo Dividenddoes biovf pay dividends · biovf dividend yieldDividend history
Shares Outstanding344.3Mbiovf shares outstanding · biovf floatShares outstanding history
Next EarningsJul 16, 2026Est.biovf earnings date · biovf next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$28.17B▲ +8.22% YoY
202320242025
swedish orphan biovitrum ab (publ) revenue · biovf revenue 2025
FY 2025Net Income$476.8M▼ 87.73% YoY
202320242025
swedish orphan biovitrum ab (publ) net income · biovf profit 2025
FY 2025EPS$1.39▼ 87.77% YoY
202320242025
biovf eps · swedish orphan biovitrum ab (publ) earnings per share 2025
TTM:Revenue: $28.88BNet Income: $936.3MEPS: $2.70View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold1 analystsis biovf a buy · biovf analyst rating
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$47.35Current
$Avg Target
$High
biovf price target · biovf 12 month forecast

Total: 1 · Buy rate: 0.0%

Stock Performance

Full History
1D-0.26%
1W-0.25%
1M-0.25%
3M+14.59%
YTD+34.33%
1Y+48.02%
5Y+144.70%

About Swedish Orphan Biovitrum AB (publ)

CEOGuido Oelkers
IPO DateJan 8, 2021
Employees1,895
CountrySE
Websitesobi.com

Swedish Orphan Biovitrum AB (publ) Operating under the ticker BIOVF, Swedish Orphan Biovitrum AB (publ) is a specialized biotechnology company dedicated to the research, development, manufacturing, and commercialization of pharmaceutic…

what is swedish orphan biovitrum ab (publ) · biovf stock overview · swedish orphan biovitrum ab (publ) company profile · who is swedish orphan biovitrum ab (publ) ceo · biovf OTC · swedish orphan biovitrum ab (publ) headquarters · swedish orphan biovitrum ab (publ) business segments

About Stock Overview & Key Data

Swedish Orphan Biovitrum AB (publ) (BIOVF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Jan 8, 2021. As of the latest trading session, BIOVF stock price is $47.35, with a market capitalization of $16.4B. The stock has returned +48.02% over the past 12 months and +34.33% year-to-date.

According to 1 Wall Street analysts, the consensus rating for Swedish Orphan Biovitrum AB (publ) stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, Swedish Orphan Biovitrum AB (publ) reported revenue of $28.2B and net income of $476.8M. For detailed data — including Swedish Orphan Biovitrum AB (publ) revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Swedish Orphan Biovitrum AB (publ) (BIOVF) stock price is $47.35. The stock is traded on OTC under the ticker symbol BIOVF. The 52-week range is $27.06 – $48.00.

BIOVF stock priceBIOVF quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice